Company Overview and News

 
Nikkei rises as easing U.S.-China trade tensions support dollar, exporters

2018-05-21 reuters
TOKYO, May 21 (Reuters) - Japan’s Nikkei share average rose on Monday as the dollars’ rise against the yen supported some exporters after news of easing U.S.-China trade tensions, but weakness in financial stocks kept wider gains limited.

 
Nikkei rises as U.S.-China trade tensions put "on hold"

2018-05-21 reuters
TOKYO, May 21 (Reuters) - Japan’s Nikkei share average rose on Monday morning as exporters were boosted by a rise in the dollar rise against the yen.

 
Philip Morris CEO Says IQos Needs Cultural, Rural Spin for Japan - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Japan Tobacco's (JAPAF) Q1 2018 Results - Earnings Call Transcript

2018-05-03 seekingalpha
[Interpreted] Thank you for waiting. Thank you very much for joining the JT Group Consolidated Financial Results Meeting for the First Quarter of 2018. I would like to open the meeting. First, Naohiro Minami, the Chief Financial Officer, will make a presentation for 15 minutes followed by the Q&A session. And the meeting will be about 60 minutes. I would like to start the presentation.

 
Japan Tobacco 2018 Q1 - Results - Earnings Call Slides

2018-05-02 seekingalpha
The following slide deck was published by Japan Tobacco in conjunction with their 2018 Q1 earnings call.

 
Tobacco's Future Is High Tech, but Regular Cigs Still Dominate - Bloomberg

2018-05-01 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Japan Tobacco’s Push Abroad Offsets Weaker Domestic Demand - Bloomberg

2018-05-01 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
P80-M worth of smuggled, fake cigarettes found in Malabon, Manila

2018-04-22 newsinfo.inquirer.net
An anti-cigarette smuggling task force uncovered smuggled and fake cigarettes worth about P80 million in Malabon and Manila last week amid higher prices of the so-called sin product due to the government’s first tax reform package, the two leading tobacco manufacturers said.

1
Excise tax increase triggers widespread cigarette smuggling

2018-04-16 bworldonline
THE BUREAU of Internal Revenue (BIR) said smuggled cigarettes are currently flooding the market, in response to the rise in excise taxes this year.

1
Cigarette smuggling on the rise – BIR

2018-04-16 business.inquirer.net
Cigarette smuggling is on the rise partly due to higher prices as a result of increased excise taxes under the first tax reform package, Internal Revenue Commissioner Caesar R. Dulay said on Monday.

 
Japan’s new fiscal year starts amid government scandal and higher food prices

2018-04-02 japantimes.co.jp
The government, along with businesses, marked the first business day of fiscal 2018 on Monday, with the former pledging revival after being hit by scandals while some food and beverage producers hiked prices due to increasing personnel and raw material expenses.

 
Menlo Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

2018-03-28 globenewswire
REDWOOD CITY, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant, for the treatment of pruritus associated with various underlying dermatologic conditions and for refractory chronic cough, today announced financial results for the fourth quarter and year ended December 31, 2017 and provided an update on its clinical development programs.

 
PAOK Fans Defend Gun-Toting Soccer Boss Savvidis, in Hiding

2018-03-26 thenationalherald
He may be a wanted man in Greece, but fans of the Thessaloniki-based PAOK soccer team love its owner, Ivan Savvidis, who’s in hiding after taking a gun onto the field while protesting a goal waved off against rival AEK of Athens.

 
Gun-Toting Russian Who Charged Onto a Soccer Field Just Became a Billionaire - Bloomberg

2018-03-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
A vote of confidence in the Philippines

2018-03-20 bworldonline
Foreign Direct Investments (FDI) recorded an all-time high in President Rodrigo R. Duterte’s first full year in office, reaching $10 billion in 2017 and surpassing the government’s $8 billion target. The 2017 figures came on the heels of the widely circulated US News & World Report, which cited the Philippines as one of the top countries to invest in, even outranking our neighbors such as Indonesia, Malaysia, and Singapore.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 006474535